There are presently two HPV vaccines on the marketplace, however if there was any regard for sound clinical proof, neither would be promoted as greatly as they are. The first, Gardasil, was certified by the United States Food and Drug Administration (FDA) in 2006. It is now advised as a regular vaccination for women and women in between the ages of 9-26 in the United States.
Oncology Dietitian Exposes Fraud in CDC’s HPV Vaccine Effectiveness Study
On October 25, 2011, the CDC’s Advisory Committee on Immunization Practices likewise voted to suggest providing the HPV vaccine to males between the ages of 11 and 21. The second HPV vaccine, Cervarix, was certified in 2009.
Most just recently, an oncology dietitian explained substantial discrepancies in a brand-new HPV vaccine effectiveness research study published in the Journal of Infectious Diseases, which assessed data from the National Health and Nutrition Examination Surveys (NHANES), 2003-2006 and 2007-2010.The study pointed out that HPV vaccine uptake among girls in the United States has been low however concluded that:
” Within 4 years of vaccine introduction, the vaccine-type HPV prevalence decreased amongst women aged 14– 19 years regardless of low vaccine uptake. The approximated vaccine efficiency was high.”
Evaluating the Overall Impact of the HPV Vaccine
In her article, Sharlene Bidini, RD, CSO, explains that the study’s conclusion was based upon 740 ladies, of which only 358 were sexually active, and of those, only 111 had received at least one dosage of the HPV vaccine. In essence, the large bulk was unvaccinated, and almost half were not at risk of HPV considering that they weren’t sexually active.
” If the research study authors were trying to identify vaccine efficiency, why did they include the women who had not gotten a single HPV shot or did not report making love?” she writes.
” Table 1 from the journal article compares 1,363 ladies, aged 14-19, in the pre-vaccine age (2003-2006) to all 740 girls in the post-vaccine period (2007-2010) regardless of sexual history or immunization status.”
In the pre-vaccine period, an estimated 53 percent of sexually active women in between the ages of 14-19 had HPV. In between 2007 and 2010, the general prevalence of HPV in the same demographic decreased by simply over 19 percent to an overall frequency of nearly 43 percent.
As Bidini explains, this decrease in HPV prevalence can NOT be claimed to be due to the efficiency of HPV vaccinations. On the contrary, the information plainly reveals that it was the unvaccinated ladies in this group that had the best result!
See also: Side Effects of Mercury in Vaccines
” In 2007-2010, the overall occurrence of HPV was 50 percent in the immunized ladies (14-19 years), however just 38.6 percent in the unvaccinated women of the same age.
Therefore, HPV occurrence dropped 27.3 percent in the unvaccinated ladies, however only declined by 5.8 percent in the vaccinated group. In 4 from 5 different procedures, the unvaccinated women had a lower occurrence of HPV,” she composes.
Furthermore, in the single circumstances where unvaccinated ladies had a 9.5 percent greater occurrence of HPV, a note specified that the relative basic error was greater than 30 percent, leading Bidini to presume that “the self-confidence period values should have been incredibly wide. For that reason, this certain value goes through too much difference and doesn’t have much value.”
Another reality hidden among the reported information was that amongst the 740 ladies consisted of in the post-vaccine age (2007-2010), the occurrence of high-risk, non-vaccine types of HPV also significantly decreased, from just under 21 percent to simply over 16 percent.
So, across the board, HPV of all types, whether consisted of in the vaccine or not, declined. This indicates a reduction in HPV occurrence that has nothing to do with vaccine protection. Besides, vaccine uptake was extremely LOW to start with.
All in all, one can conclude that there were serious design flaws involved in this research study– whether deliberate or not– leading the researchers to mistakenly conclude that the vaccine efficiency was “high.” Clearly the efficiency of the vaccine was anything but high, considering that the unvaccinated group fared far better across the board.
Case Report of a Gardasil Death Confirms Presence of HPV DNA Fragments
Earlier this year, a lab scientist, who found HPV DNA fragments in the blood of a teenage lady who died after receiving the Gardasil vaccine, published a case report in the peer examined journal Advances in Bioscience and Biotechnology. The otherwise healthy woman died in her sleep 6 months after receiving her 3rd and final dosage of the HPV vaccine. A full autopsy exposed no cause of death.
Sin Hang Lee with the Milford Molecular Laboratory in Connecticut validated the presence of HPV-16 L1 gene DNA in the girl’s postmortem blood and spleen tissue. These DNA fragments are likewise found in the vaccine. The fragments were protected from degradation by binding firmly to the particulate aluminum adjuvant used in the vaccine.
” The significance of these HPV DNA fragments of a vaccine origin discovered in post-mortem materials is not clear and warrants further examination,” he wrote.
Lee suggests the existence of HPV DNA pieces of vaccine origin might offer a possible description for the high immunogenicity of Gardasil, indicating that the vaccine has the ability to provoke an exaggerated immune response. He mentions that the rate of anaphylaxis in ladies getting Gardasil is far greater than normal– supposedly five to 20 times higher than any other school-based vaccination program!
HPV Vaccine Is Associated with Serious Health Risks, Including Sudden Death
Numerous women are not aware that the HPV vaccine Gardasil might really increase your risk of cervical cancer. At first, that info came straight from Merck and existed to the FDA prior to approval. According to Merck’s own research, if you have been exposed to HPV stress 16 or 18 previous to receipt of Gardasil vaccine, you could increase your risk of precancerous lesions, or even worse, by 44.6 percent.
Other illness associated with Gardasil vaccine include immune-based inflammatory neurodegenerative disorders, suggesting that something is triggering the body immune system to overreact in a destructive way– sometimes fatally.
Between June 1, 2006 and December 31, 2008, there were 12,424 reported adverse events following Gardasil vaccination, consisting of 32 deaths. The ladies, who were on average 18 years of ages, died within two to 405 days after their last Gardasil injection
In between May 2009 and September 2010, 16 additional deaths after Gardasil vaccination were reported.
For that timeframe, there were likewise 789 reports of “serious” Gardasil negative responses, consisting of 213 cases of permanent disability and 25 detected cases of Guillain-Barre Syndrome.
In between September 1, 2010 and September 15, 2011, another 26 deaths were reported following HPV vaccination.
As of May 13, 2013, VAERS had received 29,686 reports of unfavorable occasions following HPV vaccinations, consisting of 136 reports of death,6, in addition to 922 reports of disability, and 550 lethal adverse occasions.